# Trade Mark Journal No.2026/035 28 August 2026

## WO0000001932166 (1,5,9,10,41,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:17 June 2026
Date of designation in the UK: 17 June 2026

International priority date claimed: 14 January 2026 (European Union Intellectual Property Office (EUIPO)) (019302819)

Class 1
  Reagents for scientific and medical research use; antibodies for scientific and medical research use; microbubbles used in cell selection, cell activation, gene editing and liquid biopsy, for scientific and medical research use; kits consisting of reagents, microbubbles and ligands, namely antibodies, nanobodies, buffers, aptamers and peptides, used in cell selection, cell activation, gene editing and liquid biopsy for scientific and medical research use.
Class 5
  Reagents for medical use; antibodies for medical use; microbubbles used in cell selection, cell activation, gene editing, and liquid biopsy for medical use; kits consisting of reagents, microbubbles, and ligands, namely antibodies, nanobodies, buffers, aptamers and peptides, used in cell selection, cell activation, gene editing and liquid biopsy for medical use.
Class 9
  Apparatus for separating, activating, isolating, preparing, collecting, expanding and cultivating cells, for gene editing and liquid biopsy, for laboratory and scientific use; cell separators for laboratory use; cell sorters for laboratory use; cell analyzers, not for medical purposes; bioreactors for cell culturing and expansion for scientific use; devices for microbubble suspension preparation for laboratory and scientific use and relevant components and accessories, namely tubing, adapters and spikes.
Class 10
  Apparatus for separating, activating, isolating, preparing, collecting, expanding and cultivating cells, for gene editing and liquid biopsy, for medical use and clinical use; cell separators for medical use; cell sorters for medical use; cell analyzers for medical purposes; bioreactors for cell culturing and expansion for medical and clinical use; devices for microbubble suspension preparation for medical and clinical use and relevant components and accessories, namely tubing, adapters and spikes.
Class 41
  Medical training and teaching in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for medical research and medical use; training and teaching in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for scientific use; arranging and conducting of conferences, congresses, workshops and webinars in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for medical research and medical use; arranging and conducting of conferences, congresses, workshops and webinars in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for scientific use.
Class 42
  Medical and scientific research in relation to cell therapy, cell selection, cell activation, gene editing and liquid biopsy; medical and scientific research in relation to cell selection, cell activation, gene editing and liquid biopsy for use in cell therapy; medical and scientific research in relation to cell therapy; providing medical and scientific research information in relation to cell therapy, cell selection, cell activation, gene editing and liquid biopsy; providing medical and scientific research information in relation to cell therapy, cell selection, cell activation, gene editing and liquid biopsy for use in cell therapy; providing medical and scientific research information in relation to cell therapy.

BRACCO IMAGING S.p.A.

Representative: SOCIETÀ ITALIANA BREVETTI S.P.A., Via Carducci 8, I-20123 Milano (MI), ITALY